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ABSTRACT
Aim: To test the effect of folic acid supplements taken throughout pregnancy on children’s
psychosocial development.
Method: A randomised controlled trial of folic acid supplementation in pregnancy, with
parental rating using the Resiliency Attitudes and Skills Profile (RASP), the Strengths and
Difficulties Questionnaire (SDQ) and the Trait Emotional Intelligence Questionnaire Child
Short Form (TEIQue-CSF). Children aged 6–7 whose mothers received folic acid
throughout pregnancy (n = 22) were compared to those whose mothers only received it
during the first trimester (n = 17).
Results: Children whose mothers received the full-term supplement scored significantly
higher on emotional intelligence and resilience. Hierarchical multiple regression analysis
identified folate level at 36th gestational week as an important predictor of emotional
intelligence (EI) and resilience.
Conclusion: Although conclusions must be drawn with caution, this research presents a
number of potential implications, the main one being a proposed policy recommendation
for women to take folic acid for the duration of pregnancy rather than stopping at the end of
the first trimester. The second is the potential for future research to explore the possible
psychological and social development benefits and in line with this to try and identify the
explanatory mechanism involved.
INTRODUCTION
Pregnancy is a time when nutritional needs are increased
due to physiological changes of the mother and the
metabolic demands of the embryo/foetus (1). During this
period, proper maternal nutrition is vital for optimal health
for both mother and child. Folate has been identified as one
particular micronutrient crucial for development particu-
larly during the periconceptional period (about one month
before and one month after conception), providing a range
of benefits for both the mother and child (2). Folate is
essential to synthesise, repair and methylate DNA; there-
fore, the demand for folate increases during pregnancy to
aid rapid cell division and growth which is vital for foetal,
placental and maternal growth and development (3).
Substantial evidence exists regarding the protective effect
of folic acid supplementation during the first trimester
against neural tube deficits (NTDs) (4) and other physical
health issues (e.g. low infant birthweight and pre-eclampsia)
(5). This evidence has led to clear recommendations by
governments worldwide for women of reproductive age to
take 400 lg/day folic acid from preconception to the end of
first trimester (6) and has led to mandatory food
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Key notes
 Effects of folic acid supplementation during the first
trimester of pregnancy have been tested, but little is
known of the effects of continued supplementation
throughout pregnancy.
 This small randomised control study has found that
children whose mothers continued supplementation
for the duration of pregnancy exhibited higher scores
on emotional intelligence and resilience.
 The study provides a basis for future research which
may impact on clinical guidelines for folic acid supple-
mentation.
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fortification programmes (7). There is also evidence to
suggest that higher folate status will have a positive impact
on children’s cognitive and neurological development (8).
This raises questions about whether the benefits of supple-
mentation extend to other aspects of psychological devel-
opment in children. It is generally recognised that cognitive
development goes hand in hand with socio-emotional
development in children and that both are built into brain
development (9); emotional intelligence and resilience
being of particular interest (10,11).
Emotional intelligence (EI) refers to the ability to
perceive, control and evaluate emotions, including the
person’s ability to carry out accurate reasoning about
emotions and the ability to use emotions and emotional
knowledge to enhance thought (12). Resilience is defined as
bounce back ability in the face of adversity, commonly
described as positive or protective processes that reduce
maladaptive outcomes under conditions of risk (11,13). EI
and resilience often provide children with protection
against internalising and externalising problems which pose
a variety of social, emotional and psychological difficulties
for the child during childhood and in adult life (14).
It is unlikely that folic acid would have a direct impact on
psychological attributes. but it could be argued that the
physical health benefits from supplementation could pro-
mote healthy psychological development through a range of
environmental factors. The World Health Organisation (15)
identified that poor physical health in infancy can lead to
difficulties with feeding and that physical and neurological
health problems increase as birthweight decreases (16).
This in turn can cause developmental vulnerabilities in the
child’s temperament (17).
To date, most research has focused on maternal folate
intake during the first trimester due to the Department of
Health recommendations; however, few studies have con-
sidered the impact of supplemental folic acid during the
second and third trimester and from those that have
findings are inconclusive. One study from the Ma’anshan-
Anhui Birth Cohort Study (MABC) in China found that
continued supplementation throughout pregnancy was
associated with increased birthweight of offspring (18).
However, this was an observational study based on moth-
ers’ self-reports of folate intake and it is not clear if effects
were negative. The only randomised control trial (RCT) in
the area found that continued supplementation can
increase maternal and cord blood folate status and prevent
the increase in homocysteine concentration that otherwise
occurs in late pregnancy and recommends further study
(19).
The aim of this study was to follow up a subsample of
mothers and children from the original Folic Acid Supple-
mentation in the Second and Third Trimester (FASSTT)
study (Fig. 1) to assess strengths and difficulties, emotional
intelligence and resilience in the children now aged seven
years. It was hypothesised that children of mother’s who
continue to take folic acid supplements throughout preg-
nancy would exhibit differences in a positive direction in
strengths and difficulties, EI and resilience from those who
discontinued supplementation at the recommended
12 weeks. Furthermore, it was hypothesised that higher
levels of folate will predict higher scores on emotional
intelligence and resilience.
METHODOLOGY
Design
The original RCT (registered at controlled-trials.com as
ISRCTN19917787) was conducted in 2006 and has been
described in detail elsewhere (19). Briefly, this study inves-
tigated the effect of Folic Acid Supplementation in the
Second and Third Trimester and the health outcomes of the
mother and newborn (FASSTT study; ISRCTN19917787).
Healthy pregnant women (n = 119) aged 18–35 years, with
singleton pregnancies and without pregnancy complica-
tions, who had taken folic acid supplementation during the
first trimester of pregnancy (as universally recommended)
were recruited from antenatal clinics at the 14th gestational
week. At the beginning of the second trimester, participants
were randomly assigned to receive either 400 lg/day of folic
acid or a placebo for 26 weeks. This study was a follow-up
investigation when children were seven years old (See Fig. 1
for diagrammatic protocol).
Participants
Mother–child pairs were recruited from the participants
of the original FASSTT study when the child was aged six
to seven years (M = 6.74, range 6.3–7.3 years). A total of
39 children (14 male children and 25 female children)
were assessed during the current study. Participants in the
original study were randomly assigned to an experimental
group (n = 22) who continued folic acid supplements
throughout the pregnancy duration, and a control group
(n = 17) who received a placebo instead of folic acid
supplementation after the required 12 weeks. Participants
were assigned a unique identification code to ensure
confidentiality and anonymity. For this study, we
recruited 22 mother–child pairs from the experimental
condition and 17 mother–child pairs from the control
condition.
Measures
Demographical details including the child’s age, sex and
anthropometric measurements (height, weight, waist
circumference, head circumference and body fat) were
retrieved from the original study. Mothers were then asked
to rate their child on the Resiliency Attitudes and Skills
Profile (RASP) and the Strengths and Difficulties Ques-
tionnaire (SDQ), and the Trait Emotional Intelligence
Questionnaire Child Short Form (TEIQue-CSF).
The Resiliency Attitudes and Skills Profile (RASP) (20) is
a 25-item scale which measures seven dimensions of
resilience (creativity, humour, independence, initiative,
insight, relationships and values orientation). It asks
parents to rate items relating to how the child copes with
everyday challenges on a seven-point scale ranging from
‘disagree completely’ to ‘agree completely’. Higher scores
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reflect more resilience. The RASP has been found to have
adequate internal consistency, concurrent validity, conver-
gent and discriminant validity (20). In the present sample,
the Cronbach’s alpha was 0.95 for the parent reported child
resilience.
The Strengths and Difficulties Questionnaire (SDQ) is
one of the most widely used brief questionnaires for
assessing child problems (21). It is a brief multidimensional
measure of psychological adjustment of children aged three
to 16 years. It is freely available as both a self-report and a
Mother Participant
• Informed consent
• Health & Lifestyle 
questionnaire
• Parenting style 
questionnaires
(aged 7 years only)
Withdrawal before randomisation 
(n 36)
Women eligible for participation onto the FASSTT trial
(Questionnaires and blood samples collected at 14th GW) n 226
Child Participant
• Cognitive 
assessment
• Anthropometric 
Measurements
• Buccal Swab (aged 
7 years only)
Folic Acid 
(400 µg/d) (n 96)
Placebo
(n 94)
Excluded from the intervention (n 71)
Folic Acid 
(n 59)
Placebo
(n 60)
Mother–child pairs completed follow up study:
Age 8 years (n 74) Reference 20
Blood Sample 14th GW
Randomisation
Blood Sample 36th
Completed the 
intervention
FASSTT 
Offspring Trial
Mother –child pairs invited to take in a follow up study when the 
child was aged 7 years
Ethical approval sought from the Office for Research Ethics 
Committee in Northern Ireland (ORECNI)
Mother –child pairs provided with information leaflets and 
contacted within 2 weeks to determine interest and complete 
screening questionnaire.  Appointment booked.
A subsample of mothers (n 39) completed psychological measures 
on behalf of their child (RASP; SDQ; TEIQue-CSF) – reported in 
the current study
GW
Follow up study
Figure 1 Diagrammatic protocol of the FASSTT offspring trial.
Table 1 Levels of serum folate present in experimental and control group members at 14th and 36th Gestational Weeks and at birth
Variable
Experimental (n = 22) Control (n = 17)
Mann–Whitney U-value pMedian Interquartile range Median Interquartile range
14th GW Serum Folate (ng/mL) 18.25 14.22 21.79 16.98 160.00 0.444
Serum Folate (nmol/L) 58.02 45.22 69.29 54.00 160.00 0.444
36th GW Serum Folate (ng/mL) 16.79 20.78 8.44 10.50 63.00 0.007
Serum Folate (nmol/L) 53.41 66.07 26.84 33.39 94.50 0.009
At birth Serum Folate (ng/mL) 37.57 17.77 22.69 12.34 37.00 0.01
Serum Folate (nmol/L) 119.49 56.49 72.15 39.23 98.00 0.01
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proxy report questionnaire and has been translated into 60
languages. The SDQ is comprised of 25 items which are
divided into five scales, each with five items. These items
generate scores for Conduct Problems (⍺ = 0.81), Hyper-
activity (⍺ = 0.86), Emotional Symptoms (⍺ = 0.83), Peer
Problems (⍺ = 0.80) and Prosocial Behaviour (⍺ = 0.78).
Each item is rated with a three-point Likert-type scale of
not true (score 0), somewhat true (score 1) and certainly
true (score 2), the total difficulties score is the summed
score of the conduct, hyperactivity, emotional and peer
problem scales, giving a possible total between 0 and 40.
The prosocial behaviour scale is the only scale rated in a
positive direction and provides a separate measure. The
mother rating version was used in this study, as the
self-report version is unsuitable for children of this age.
The Trait Emotional Intelligence Questionnaire Child
Short Form (TEIQue-CSF) (22,23) measures in children
nine of the 15 adult facets of EI, and has been shown to
display acceptable levels of internal consistency in two
separate samples and also displayed temporal stability
(⍺ = 0.79) similar to that found in adult samples. It has a
self-rating version suitable for use in children as young as
eight years old and other rating (in this case the mother)
version which was suitable for the current sample.
Procedure
The mother–child pairs (n = 52) who participated in the
first study had already consented to be recontacted for
future studies. Permission was obtained from the par-
ticipants’ consultant obstetrician to recontact these 52
mothers by letter inviting them to take part in the
follow-up study. Included in the letter were a partici-
pant information sheet which participants were asked to
read, and a stamped addressed envelope providing
participants an opportunity to decline participation in
the study. Of those contacted, 39 responded positively
and agreed to participate in the study. Due to lack of
funding at this stage, we were unable to follow-up the
full sample.
Ethical considerations
Ethical approval was granted in full from the Office of
Research Ethics Committees in Northern Ireland
(ORECNI) (reference number 05/Q2008/21) on 25th
August 2012, Approval from the Northern Health
and Social Care Trust was received on 28 December
2012. A substantial amendment to the study was
approved by ORECNI on 6th July 2016 (Reference 12/
NI/0077).
RESULTS
The folate status of the experimental (n = 22) and control
groups (n = 17) was measured at 14 weeks and 36 weeks of
gestation and again at birth. To ensure randomisation had
been successful, these measurements were compared using
nonparametric Mann–Whitney U-tests. Table 1 shows no
significant difference between the experimental and control
group at the 14th gestational week (GW), but there is a
significant difference between the groups at the 36th GW
and at birth as expected. These are illustrated in scatter dot
diagrams in Figure 2A–C.
Figure 2 Mother’s Serum Folate levels for experimental and placebo groups at
14 and 36 GW and at birth.
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To further test the quality of the RCT and ensure, there
was no significant difference between the experimental and
control group participants Mann–Whitney U-tests were
conducted comparing the groups on a range of character-
istics. Table 2 shows the range of characteristics compared
between the groups.
The experimental (n = 22) and control groups (n = 17)
were compared using Mann–Whitney U-tests and the main
effects are summarised in Table 3.
Total scores for both EI and Resilience indicate a
significant difference between experimental and control
groups. SDQ scores highlighted a slight difference between
the groups with the experimental group reporting less
difficulties; however, this was not significant. These are
illustrated in scatter dot diagrams in Figure 3.
Emotional intelligence (TEIQue-CSF)
Children assigned to the experimental group scored
significantly higher on Total EI (Median = 64.50,
Interquartile range = 8.50) compared to children in the
control group (Median = 57.00, Interquartile range = 7.00,
p = 0.001). These results suggest that folic acid supple-
mentation throughout pregnancy may have a positive
effect on the children’s EI at this age. There were 15
individual factors of EI measured using this scale (listed in
Table 3) and 10 of these were nonsignificant. Significant
values were as follows: Emotional Expressiveness
(p = 0.006), Empathy (p = 0.026), Emotional Regulation
(Median = p = 0.038), Adaptable (p = 0.026) and Stress
Management (p = 0.03).
Strengths and difficulties (SDQ)
The total difficulties measured using the SDQ suggested a
slight difference between the experimental group
(Median = 6.00, Interquartile range = 4.25) and control
group (Median = 11.00, Interquartile range = 12.50); how-
ever, this was a nonsignificant difference. The only individ-
ual facet of the scale to produce significant scores was
conduct problems with the control group exhibited higher
scores than the experimental group (p = 0.038) (listed in
Table 3).
Resilience (RASP)
Experimental group members scored significantly higher
on total resilience (Median = 4.18, Interquartile
range = 0.31, p = 0.001) in comparison with members of
the control group (Median = 3.75, Interquartile
range = 0.36, p = 0.001). Findings suggest that children
belonging to the experimental group are more resilient in
comparison with their peers in the control group. The
RASP measured seven separate facets of Resilience (listed
in Table 3) all of which were significant values, these were
as follows: Creativity (p = 0.008), Humour (p = 0.003),
Independence (p = 0.001), Initiative (p = 0.017), Insight
(p = 0.006), Relationships (p = 0.003) and Values Orien-
tation (p = 0.007).
Table 2 General characteristics of FASSTT mothers and children Trial participants
Maternal characteristics
Characteristics
Treatment (N = 22) Control (N = 17)
Mann–Whitney U-value pMedian Interquartile range Median Interquartile range
Age (year) 29.40 4.09 27.85 4.63 0.124 1.97
BMI (kg/m2) 25.53 5.28 24.55 3.67 0.517 0.984
Education (years) 17.23 7.63 15.24 7.50 0.420 0.693
Frequency Frequency v2 p
Smokers 3/22 2/17 0.030 0.625
Alcohol users 1/22 1/17 0.035 0.688
Married 21/22 15/17 1.382 0.417
Homeowner 17/22 13/17 2.174 0.305
Child characteristics
Characteristics
Treatment (N = 22) Control (N = 17)
Mann–Whitney U-value pMedian Interquartile range Median Interquartile range
Age at assessment (year) 6.75 0.23 6.74 0.12 180.00 0.839
Birth weight (g) 3394.06 612.97 3347.50 387.700 182.00 0.887
Length (cm) 51.44 2.28 50.77 1.6015 147.00 0.382
Head size (cm) 33.93 1.53 34.68 1.60 147.00 0.375
Frequency Frequency v2 p
Breastfed from birth 9/22 9/17 1.029 0.250
Gender, female 15/22 10/17 0.365 0.393
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Hierarchical multiple regression analysis (HMRA)
The next stage in analysis was to test the proposed
relationships using four separate HMRA as shown in
Table 4. Firstly, EI was entered as the dependent variable
with characteristics of the child including gender, weight,
height and waist and head circumference entered as
predictor variables in step 1 which accounted for a small
amount of variance (8%) (F5,32 = 0.58; p > 0.05, R
2 = 0.08,
R2Adjusted = 0.06). Maternal characteristics including BMI
and age were added for step 2 which accounted for a further
17% of the variance (F7,30 = 0.87; p > 0.05, R
2 = 0.17,
R2Adjusted = 0.025). The mother’s level of folate measured
at the 36th GW was added to the model on step 3 and
accounted for a significant amount of the variance (42%)
(F8,29 = 0.2.6; p < 0.05, R
2 = 0.42, R2Adjusted = 0.26). The
level of folate measured at 36th GW and the child’s height
had a significant partial correlation with EI.
A second HMRA was conducted with resilience as the
dependent variable as shown also in Table 4. Again, this
was a three-step HMRA with the child’s characteristics
(gender, weight, height and waist and head circumference)
entered on step 1 and accounting for 11% of the variance
(F5,32 = 0.78; p > 0.05, R
2 = 0.11, R2Adjusted = 0.03). The
mother’s BMI and age were added to the model on step 2
and accounted for 17% of the variance (F7,30 = 0.85;
p > 0.05, R2 = 0.17, R2Adjusted = 0.03). The folate level at
36th GW was added on step 3 explaining a total of 36% of
the variance (F8,29 = 2.0; p > 0.05, R
2 = 0.36, R2Adjusted =
0.18). This predictor variable also produced a significant
partial correlation.
The third HMRA was carried out with total difficulties as
the dependent variable (Table 4). Similarly to the other
regression analyses, this was a three-step HMRA with step 1
of the model (child characteristics) accounting for 4% of the
variance (F5,32 = 0.26; p > 0.05, R
2 = 0.04, R2Adjusted =
0.11). Step 2 (Mothers BMI and age) accounting for
25% of the variance (F7,30 = 1.4; p > 0.05, R
2 = 0.25,
R2Adjusted = 0.07) and step 3 (folate level at 36
th GW)
explaining a total of 28% of the variance (F8,29 = 1.4;
p > 0.05, R2 = 0.28, R2Adjusted = 0.09). None of the
Table 3 Experimental versus control group descriptive statistics and main effects
Variable
Experimental (N = 22) Control (N = 17)
Mann–Whitney U-value pMedian Interquartile range Median Interquartile range
Emotional intelligence scores (TEIQue-CSF)
EI total 64.50 8.50 57.00 7.00 65.00 0.001
Emotional expressive 4.50 1.00 4.00 0.50 99.50 0.006
Empathy 4.00 1.25 3.00 1.00 114.00 0.026
Self-motivation 4.00 1.00 4.00 2.00 139.00 0.154
Emotional regulation 4.00 1.25 3.00 2.00 117.00 0.038
Happiness 5.00 1.00 4.00 1.00 127.500 0.056
Social awareness 5.00 1.00 4.00 1.00 131.00 0.076
Low impulsivity 4.00 3.00 4.00 1.00 135.50 0.098
Emotional perceptive 4.00 0.25 4.00 2.00 164.00 0.467
Self esteem 4.50 1.00 4.00 1.00 132.50 0.082
Assertiveness 4.00 0.25 4.00 1.00 137.50 0.123
Emotion management 4.00 0.25 4.00 0.50 160.00 0.346
Optimism 4.00 0.25 4.00 0.25 157.00 0.309
Relationships 5.00 1.00 4.00 1.00 133.00 0.076
Adaptable 4.00 1.00 4.00 1.00 115.50 0.026
Stress management 4.00 0.50 3.00 1.00 115.50 0.030
SDQ scores
Difficulties total 6.00 4.25 11.00 12.50 143.50 0.217
Emotional difficulties 2.50 4.25 3.00 7.00 181.00 0.863
Conduct problems 0.50 7.00 3.00 3.50 115.50 0.038
Hyperactivity 3.00 4.50 4.00 7.00 161.00 0.455
Peer problems 1.00 2.00 1.00 5.00 182.00 0.884
Prosocial behaviour 10.00 1.00 9.00 4.00 160.00 0.426
RASP scores
Resilience total 4.18 0.31 3.75 0.36 38.50 0.001
Creativity 4.25 0.56 3.75 0.63 94.00 0.008
Humour 3.88 1.00 3.25 1.13 83.00 0.003
Independence 4.00 0.75 3.63 0.69 70.50 0.001
Initiative 4.00 0.60 3.60 0.80 103.50 0.017
Insight 4.29 0.64 3.86 0.57 91.00 0.006
Relationships 4.50 0.53 4.00 0.44 82.50 0.003
Values orientation 4.38 0.56 4.00 0.63 93.50 0.007
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individual variables produced significant partial correla-
tions in this model.
The final HMRA used prosocial behaviour as the
dependent variable. The first step of the model accounted
for 17% of the variance (F5,32 = 1.3; p > 0.05, R
2 = 0.17,
R2Adjusted = 0.04) with the child’s gender producing a
significant partial correlation. After adding the mothers
BMI and age to the model in step 2, 23% of the variance
was accounted for (F7,30 = 1.25; p > 0.05, R
2 = 0.23,
R2Adjusted = 0.05). The child’s gender remained a signifi-
cant partial correlation. Step 3 increased the total variance
explained to 24% in total (F8,29 = 1.16; p > 0.05,
R2 = 0.24, R2Adjusted = 0.03); however, no significant par-
tial correlations were present in the final step of the
model.
DISCUSSION
The aim of the present study was to test a subsample of
participants from the original FASSTT study conducted in
2006 to assess strengths and difficulties, emotional intelli-
gence and resilience in the children now in their seventh
year of age. It was suggested that children of mothers who
continued to take folic acid throughout pregnancy might
have better psychosocial performance (exhibiting differ-
ences in strengths and difficulties, EI and resilience)
compared to those whose mothers received placebo during
the second and third trimester. Results demonstrated that
children whose mothers were in the experimental group
rated higher overall on EI and resilience as well as rating
lower on the conduct problems dimension of the SDQ. To
date, the literature has detailed the physical, cognitive and
neurological benefits of folic acid supplementation with
reasonable consistency (4,6). However, no research exists
on the effect of folic acid on positive psychological factors
such as emotional intelligence and resilience. The present
study provides some tentative evidence to suggest that a link
may exist between the beneficial effect of folic acid on brain
development and subsequent psychological factors in child
development.
It was unlikely that folic acid supplementation directly
affected the psychological attributes of the children. How-
ever, it is typical for children’s physical, cognitive and
psychological development to occur in synchrony and the
more physically healthy the child, the more likely appro-
priate cognitive and psychological and emotional develop-
ment would occur.
Previous research has linked folic acid supplementation
with a number of positive effects. Children of mothers who
had retrospectively reported taking the supplement showed
increased general cognitive performance at ages three to
four years (24). Language delay in children has been
associated with lower levels of folate in foetal blood (25).
In another study, folate supplementation was associated
with improved language and motor development in chil-
dren (26). Lower folate levels have also been associated
with emotional and behavioural problems in children (27).
The above research has looked at folate supplementation in
the first trimester of pregnancy, yet the period 24–42 weeks
is crucial for brain growth (28) but there is no evidence on
the impact of folate during this period on cognitive and
psychological development.
Figure 3 Total scores on SDQ, EI and RASP for experimental and placebo
groups.
©2018 Foundation Acta Pædiatrica. Published by John Wiley & Sons Ltd 7
Henry et al. Folic Acid and child development
Given the above evidence, it could be speculated that the
physical health benefits from supplementation could pro-
mote healthy psychological and emotional development
with a range of mediating factors such as attachment style
and parenting style (29). Although speculative, the under-
lying mechanism through which this effect may be trans-
mitted is language and communication. Early language
development is associated with earlier socio-emotional
development. The dimensions of EI on which the children
scored significantly higher were emotional expressiveness,
empathy, emotional regulation, adaptability and stress
management (30). In terms of resilience, these children
scored significantly higher on dimensions of creativity,
humour, independence, initiative, insight, relationships and
values orientation. These are all areas one might expect to
be enhanced from advanced language skills and cognitive
development in general.
Research on folic supplementation has focused on the
prevention of negative effects (5) and has not ventured into
the potential for added benefits. This provides an interesting
Table 4 Hierarchical multiple regression with emotional intelligence, resilience, total difficulties and prosocial behaviour as separate dependent variables
Emotional Intelligence
Model 1 (r2 = 0.08) Model 2 (r2 = 0.17) Model 3 (r2 = 0.42*)
B SE b B SE b B SE b
Child’s gender 0.221 0.272 0.149 0.325 0.282 0.219 0.090 0.249 0.060
Weight (kg) 0.083 0.100 0.384 0.080 0.099 0.368 0.152 0.087 0.702
Height (m) 0.054 0.043 0.422 0.041 0.044 0.325 0.081 0.039 0.636*
Waist circumference (cm) 0.004 0.050 0.025 0.012 0.051 0.063 0.034 0.044 0.188
Head circumference (cm) 0.001 0.055 0.002 0.004 0.054 0.013 0.033 0.047 0.122
Maternal BMI 0.018 0.029 0.114 0.008 0.025 0.048
Maternal age 0.044 0.032 0.278 0.015 0.028 0.095
Folate level 36th GW 0.017 0.005 0.584**
Resilience
Model 1 (r2 = 0.11) Model 2 (r2 = 0.17) Model 3 (r2 = 0.36)
B SE b B SE b B SE b
Child’s gender 0.061 0.156 0.070 0.057 0.165 0.066 0.063 0.153 0.072
Weight (kg) 0.002 0.057 0.017 0.004 0.058 0.029 0.040 0.053 0.320
Height (m) 0.019 0.025 0.261 0.020 0.026 0.275 0.040 0.024 0.547
Waist circumference (cm) 0.037 0.029 0.351 0.038 0.030 0.355 0.026 0.027 0.246
Head circumference (cm) 0.007 0.031 0.044 0.006 0.031 0.036 0.024 0.029 0.154
Maternal BMI 0.021 0.017 0.229 0.016 0.015 0.171
Maternal age 0.004 0.018 0.039 0.011 0.017 0.120
Folate level 36th GW 0.008 0.003 0.510*
Total difficulties
Model 1 (r2 = 0.04) Model 2 (r2 = 0.25) Model 3 (r2 = 0.28)
B SE b B SE b B SE b
Child’s gender 2.299 4.343 0.099 0.900 4.187 0.039 2.334 4.307 0.101
Weight (kg) 0.026 1.595 0.008 0.068 1.470 0.020 0.509 1.500 0.151
Height (m) 0.312 0.691 0.158 0.163 0.654 0.082 0.403 0.676 0.204
Waist circumference (cm) 0.436 0.804 0.153 0.216 0.763 0.076 0.077 0.765 0.027
Head circumference (cm) 0.023 0.874 0.005 0.115 0.800 0.027 0.109 0.814 0.026
Maternal BMI 0.798 0.425 0.320 0.734 0.424 0.294
Maternal age 0.720 0.468 0.292 0.544 0.485 0.221
Folate level 36th GW 0.101 0.081 0.228
Prosocial behaviour
Model 1 (r2 = 0.17) Model 2 (r2 = 0.23) Model 3 (r2 = 0.24)
B SE b B SE b B SE b
Child’s gender 2.518 1.060 0.414* 2.469 1.114 0.406* 2.220 1.163 0.365
Weight (kg) 0.009 0.389 0.010 0.041 0.391 0.046 0.036 0.405 0.040
Height (m) 0.018 0.168 0.034 0.020 0.174 0.038 0.062 0.183 0.119
Waist circumference (cm) 0.059 0.196 0.079 0.051 0.203 0.068 0.075 0.206 0.100
Head circumference (cm) 0.080 0.213 0.072 0.090 0.213 0.081 0.129 0.220 0.117
Maternal BMI 0.140 0.113 0.214 0.151 0.115 0.231
Maternal age 0.051 0.124 0.079 0.082 0.131 0.127
Folate level 36th GW 0.018 0.022 0.151
*p < 0.05. **p < 0.01.
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field for future research. These findings were encouraging,
reinforcing the need for further research assessing the
children themselves.
While the sample in this study was small, it was based on
a randomised control trial thereby giving some credence to
the findings. Although conclusions must be drawn with
caution, this research presents a number of potential
implications, the main one being a proposed policy recom-
mendation for women to take folic acid for the duration of
pregnancy rather than stopping at the end of the first
trimester. The second is the potential for future research to
explore the possible psychological and social development
benefits and in line with this to try and identify the
explanatory mechanism involved.
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